EyePoint (EYPT) Non Operating Income (2010 - 2026)
EyePoint (EYPT) posted Non Operating Income of $2.91 million for Q2 2026, up 0.6% from $2.89 million a year earlier and up 24.1% from the prior quarter.
EyePoint (EYPT) Non Operating Income (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Income at EyePoint was $10.47 million, down 24.4% year-over-year; for FY2025, it came in at $11.75 million, down 22.0% from FY2024.
- In prior years, EyePoint's Non Operating Income was $15.07 million in FY2024 (+246.1%), $4.36 million in FY2023, -$2.62 million in FY2022 and -$3.14 million in FY2021.
- Quarterly Non Operating Income has run from a low of -$2.69 million in Q1 2022 to a high of $4.04 million in Q1 2024 over five years.
- On a year-over-year basis, Non Operating Income increased in three of the last eight quarters, with growth averaging 4.1%.
- The strongest year-over-year quarter for Non Operating Income in the past five years was Q1 2024, with growth of 935.1%; the weakest was Q1 2026, with a decline of 35.6%.
- According to Business Quant data, Non Operating Income for the three prior quarters was $2.34 million (Q1 2026), $2.92 million (Q4 2025) and $2.29 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | - |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | - |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | - |
| 10 | EyePoint | 31.41 Mn | -881.72 Mn | 507,000.00 | 2.91 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.91 Mn |
| Mar 31, 2026 | 2.34 Mn |
| Dec 31, 2025 | 2.92 Mn |
| Sep 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.89 Mn |
| Mar 31, 2025 | 3.64 Mn |
| Dec 31, 2024 | 3.93 Mn |
| Sep 30, 2024 | 3.39 Mn |
| Jun 30, 2024 | 3.72 Mn |
| Mar 31, 2024 | 4.04 Mn |
| Dec 31, 2023 | 2.34 Mn |
| Sep 30, 2023 | 1.79 Mn |
| Jun 30, 2023 | -159,000.00 |
| Mar 31, 2023 | 390,000.00 |
| Dec 31, 2022 | 283,000.00 |
| Sep 30, 2022 | -22,000.00 |
| Jun 30, 2022 | -190,000.00 |
| Mar 31, 2022 | -2.69 Mn |
| Dec 31, 2021 | -1.38 Mn |
| Sep 30, 2021 | -1.38 Mn |
EyePoint Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=EYPT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "EYPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=EYPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();